Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells

Biochemical and Biophysical Research Communications

Volumn 332, Issue 1, 2005, Pages 89-94

  Motomura, Wataru ^a   Tanno, Satoshi ^a   Takahashi, Nobuhiko ^a   Nagamine, Miho ^a   Fukuda, Mitsuko ^a   Kohgo, Yutaka ^a   Okumura, Toshikatsu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Extracellular signal related kinase; Growth inhibition; Mitogen activated protein kinase kinase; Pancreatic cancer cells; PPAR ; Troglitazone

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TROGLITAZONE;

ARTICLE; CANCER CELL; CELL GROWTH; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 19344376702     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.095     Document Type: Article

References (35)

1. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
2. T. Lemberger, B. Desvergne, and W. Wahli Peroxisome proliferator- activated receptors: a nuclear receptor signaling pathway in lipid physiology Ann. Rev. Cell. Dev. Biol. 12 1996 335 363
3. B.M. Spiegelman, and J.S. Flier Adipogenesis and obesity: rounding out the big picture Cell 84 1996 377 389
4. P. Sarraf, E. Mueller, D. Jones, F. King, D.J. DeAngelo, J.B. Partridge, S.A. Holden, L.B. Chen, S. Singer, C. Fletcher, and B.M. Spiegelman Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat. Med. 4 1998 1046 1052
5. J.A. Brockman, R.A. Gupta, and R.N. DuBois Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells Gastroenterology 115 1998 1049 1055
6. S. Kitamura, Y. Miyazaki, Y. Shinomura, S. Kondo, S. Kanayama, and Y. Matsuzawa Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells Jpn. J. Cancer Res. 90 1999 75 80
7. P. Tontonoz, S. Singer, B.M. Forman, P. Sarraf, J.A. Fletcher, C.D. Fletcher, R.P. Burn, E. Mueller, S. Altiok, H. Oppenheim, R.M. Evans, and B.M. Spiegelman Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptorγ and the retinoid X receptor Proc. Natl. Acad. Sci. USA 94 1997 237 241
8. T. Kubota, K. Koshizuka, E.A. Williamson, H. Asou, J.W. Said, S. Holden, I. Miyoshi, and H.P. Koeffler Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Cancer Res. 58 1998 3344 3352
9. E. Elstner, C. Muller, K. Koshizuka, E.A. Williamson, D. Park, H. Asou, P. Shintaku, J.W. Said, D. Heber, and H.P. Koeffler Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proc. Natl. Acad. Sci. USA 95 1998 8806 8811
10. E. Mueller, P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman Terminal differentiation of human breast cancer through PPARγ Mol. Cell 1 1998 465 470
11. N. Takahashi, T. Okumura, W. Motomura, Y. Fujimoto, I. Kawabata, and Y. Kohgo Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells FEBS Lett. 455 1999 135 139
12. T.H. Chang, and E. Szabo Induction of differentiation and apoptosis by ligands of peroxisome proliferator activated receptor gamma in non-small cell lung cancer Cancer Res. 60 2000 1129 1138
13. Kip1 in human pancreatic carcinoma cells Cancer Res. 60 2000 5558 5564
14. WAF/CIP1 cyclin-dependent kinase inhibitor Biochem. Biophys. Res. Commun. 261 1999 833 837
15. Kip1 accumulation which is resulted from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells Int. J. Cancer 108 2004 41 46
16. Kip1, a cyclin-Cdk inhibitor and potential mediator of extracellular antimitogenic signals Cell 78 1994 59 66
17. H. Toyoshima, and T. Hunter p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 Cell 78 1994 67 74
18. M. Nagamine, T. Okumura, S. Tanno, M. Sawamukai, W. Motomura, N. Takahashi, and Y. Kohgo PPARγ ligand-induced apoptosis through a p53 dependent mechanism in human gastric cancer cell Cancer Sci. 94 2003 338 343
19. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv. Cancer Res. 74 1998 49 139
20. M. Suhasini, H. Li, S.M. Lohmann, G.R. Boss, and R.B. Pilz Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway Mol. Cell Biol. 18 1998 6983 6994
21. J.S. Sebolt-Leopold, D.T. Dudley, R. Herrera, K.V. Becelaere, A. Wiland, R.C. Gowan, H. Tecle, S.D. Barrett, A. Bridges, S. Przybranowski, W. Leopold, and A.R. Saltiel Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo Nat. Med. 5 1999 810 816
22. A. Brunet, R.D. Roux, P. Lenormand, S. Dowd, S. Keyse, and J. Pouyssegur Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry EMBO J. 18 1999 664 674
23. J.N. Lavoie, G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegu Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38 MAPK pathway J. Biol. Chem. 271 1996 20608 20616
24. M. Kobori, S. Matsuno, T. Sato, M. Kan, and T. Tachibana Establishment of a human pancreatic cancer cell line and detection of pancreatic associated antigen Tohoku J. Exp. Med. 143 1984 33 46
25. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma J. Biol. Chem. 270 1995 12953 12956
26. M.F. Favata, K.Y. Horiuchi, E.J. Manos, A.J. Daulerio, D.A. Stradley, W.S. Feeser, D.E. Van Dyk, W.J. Pitts, R.A. Earl, F. Hobbs, R.A. Copeland, R.L. Magolda, P.A. Scherle, and K.M. Trzaskos Identification of a novel inhibitor of mitogen-activated protein kinase kinase J. Biol. Chem. 273 1998 18623 18632
27. D.T. Dudley, L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc. Natl. Acad. Sci. USA 92 1995 7686 7689
28. S. Takeuchi, T. Okumura, W. Motomura, M. Nagamine, N. Takahashi, and Y. Kohgo Troglitazone induces G1 arrest by p27Kip1 induction that is mediated by inhibition of proteasome in human gastric cancer cells Jpn. J. Cancer Res. 93 2002 774 782
29. S. Wagner, W. Bell, J. Westermann, R.P. Logan, C.T. Bock, C. Trautwein, J.S. Bleck, and M.P. Manns Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis Gastroenterology 113 1997 1836 1847
30. W. Motomura, M. Nagamine, S. Tanno, M. Sawamukai, N. Takahashi, Y. Kohgo, and T. Okumura Inhibition of cell invasion and morphological change by troglitazone in cultured human pancreatic cancer cells J. Gastroenterol. 39 2004 461 468
31. J.S. Sebolt-Leopold, D.T. Dudley, R. Herrera, K. Van Becelaere, A. Wiland, R.C. Gowan, H. Tecle, S.D. Barrett, A. Bridges, S. Przybranowski, W.R. Leopold, and A.R. Saltiel Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo Nat. Med. 7 1999 810 816
32. P.L. Rice, R.J. Goldberg, E.C. Ray, L.J. Driggers, and D.J. Ahnen Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites Cancer Res. 61 2001 1541 1547
33. M.T. Yip-Schneider, and C.M. Schmidt MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac Pancreas 27 2003 337 344
34. M.J. Boucher, J. Morisset, P.H. Vachon, J.C. Reed, J. Laine, and N. Rivard MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells J. Cell. Biochem. 79 2000 355 369
35. K.V. Bhatt, L.S. Spofford, G. Aram, M. McMullen, K. Pumiglia, and A.E. Aplin Adhesion control of cyclin D1 and p27(Kip1) levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling Oncogene 23 2005 1 13